I'm taking Nader's word on their value ; ) it sounds like a good, middle of the road / ballpark figure, given potential treatment costs already discussed. If you want to throw in IP, that would help, but as it's also unproven, a stickler would say it's not by much.
I'm not saying Brazil isn't important.. I'm saying that many are confusing people buying /selling a News event for a sea change in investors, marketwide, projections for CytoDyn's proper market cap. Which, CytoDyn is not visible enough for that. Unless I missed a CNBC spot?